How much funding has SeltaSquare raised?

SeltaSquare has raised $6.4M in total funding, most recently a Series A round.

Who are SeltaSquare's investors?

SeltaSquare's investors include KB Investment, Korea Investment Partners, SJ Investment Partners, Yuanta Investment.

When was SeltaSquare founded?

SeltaSquare was founded in 2021.

Where is SeltaSquare headquartered?

SeltaSquare is headquartered in Seongnam, South Korea.

What industry is SeltaSquare in?

SeltaSquare operates in Artificial Intelligence, Healthcare, SaaS.

How many employees does SeltaSquare have?

SeltaSquare has 11-50 employees.

SeltaSquare

Generating Safety Outcomes with Human Insight and AI

Seongnam, South Korea · Founded 2021 · $6.4M raised

Artificial Intelligence

Healthcare

SaaS

Headquarters: Seongnam
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: seltaglobal.com
Total Funding: $6.4M
Last Round: $6.4M Series AJan 2025
Rounds: 1

About

SeltaSquare is a South Korean AI-powered pharmacovigilance (PV) SaaS company founded in 2021, headquartered in Seongnam, Gyeonggi-do. The company provides an end-to-end drug safety management ecosystem through its flagship iVigilance Square platform — an AI/DX-powered system covering safety database management, literature monitoring, tabulation, and signal detection — along with expert PV/QA services and the RMP OneScope™ post-marketing safety management service. SeltaSquare serves pharmaceutical companies seeking to meet domestic and international regulatory requirements for drug safety monitoring.

Summary

SeltaSquare is an Artificial Intelligence company based in Seongnam, South Korea, founded in 2021. It has raised $6.4M in total across 1 round, most recently a $6.4M Series A round in Jan 2025. Investors include KB Investment, Korea Investment Partners and SJ Investment Partners.